Abbott Laboratories (ABT) Free Cash Flow Growth (1y) (2010 - 2026)
Abbott Laboratories (ABT) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.87% |
| Mar 31, 2026 | -1.82% |
| Dec 31, 2025 | 22.25% |
| Sep 30, 2025 | 6.61% |
| Jun 30, 2025 | 8.27% |
| Mar 31, 2025 | 48.80% |
| Dec 31, 2024 | -5.91% |
| Sep 30, 2024 | 63.17% |
| Jun 30, 2024 | 105.03% |
| Mar 31, 2024 | -17.82% |
| Dec 31, 2023 | 33.04% |
| Sep 30, 2023 | -43.06% |
| Jun 30, 2023 | -65.73% |
| Mar 31, 2023 | -56.25% |
| Dec 31, 2022 | -30.04% |
| Sep 30, 2022 | 3.26% |
| Jun 30, 2022 | 18.43% |
| Mar 31, 2022 | -22.14% |
| Dec 31, 2021 | -21.35% |
| Sep 30, 2021 | 42.68% |